Summary

Eligibility
for people ages 18-65 (full criteria)
Location
at UCLA
Dates
study started
study ends around
Principal Investigator
by Andrew Leuchter, MD (ucla)

Description

Summary

This project studies the effectiveness of brain stimulation on borderline personality disorder (BPD) symptoms. This study is blinded, randomized and will enroll up to 30 participants.

Participant will be consented for the study remotely via a secure internet platform called Zoom.

Participants will undergo up to 2 MRI scans, 2 brain wave recording sessions and up to 30 brain stimulation treatments, and complete symptom assessments and cognitive behavioral tasks on a computer. Participation requires minimum of 17 in person visits over the course of 2.5 months.

Participants are randomly assigned active or sham brain stimulation. Participants who received sham brain stimulation have the option to receive additional 15 active brain stimulation session.

Official Title

CLINICAL TRIAL: Treatment of Borderline Personality Disorder by Targeting Ventrolateral Prefrontal-amygdala Circuit With Network-based Neuronavigated Transcranial Magnetic Stimulation

Details

Borderline personality disorder (BPD) is a serious and pervasive psychiatric condition with a prevalence of 1-5% among the general population. Two core symptoms of BPD are dysfunctional emotion regulation and marked impulsivity resulting in severe psychological suffering in terms of depression and anxiety as well as maladaptive impulsive acts, particularly self-harming behaviors including suicide. Recent advances in affective neuroscience of BPD combined with progress in brain imaging and neuromodulation technologies have opened new avenues for the development of innovative, brain-based, and more effective treatments for BPD.

This project aims to test the efficacy of a novel circuit-based treatment for BPD. The investigators will utilize multimodal neuroimaging Magnetic Resonance Imaging (MRI), and electroencephalogram (EEG) and BPD-, depression- and anxiety-related clinical scales to objectively measure the impact of Transcranial Magnetic Stimulation (TMS) treatment on overall BPD as well as depressive and anxiety symptom severity. Furthermore, a battery of cognitive tasks will be used to specifically measure the effect of TMS on the neurobehavioral indicators of impulsivity and emotion regulation.

Keywords

Borderline Personality Disorder, Borderline Personality, BPD - Borderline Personality Disorder, BPD, rTMS, TMS, Transcranial Magnetic Stimulation, Transcranial Magnetic Stimulation (TMS)

Eligibility

For people ages 18-65

  • Age of 18-65
  • DSM-5 Diagnosis of BPD based upon a psychiatric evaluation and ZAN-BPD
  • Fluent English speaker
  • Signed informed consent

Locations

  • Semel Institute for Neuroscience and Human Behavior at UCLA accepting new patients
    Los Angeles 5368361 California 5332921 90024 United States
  • Semel Institute/ UCLA TMS accepting new patients
    Los Angeles 5368361 California 5332921 90024 United States

Lead Scientist at University of California Health

  • Andrew Leuchter, MD (ucla)
    Professor, Psychiatry and Biobehavioral Sciences, Medicine. Authored (or co-authored) 186 research publications

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, Los Angeles
ID
NCT07197502
Study Type
Interventional
Participants
Expecting 30 study participants
Last Updated